After Hours
$
3.80
Change
-0.12 -3.06%
Volume
Volume 1
Sep 20, 2023, 5:34 p.m.
Quotes are delayed by 20 min
Previous close
$ 3.89
$ 3.92
Change
+0.03 +0.77%
Day low
Day high
$3.78
$3.95

52 week low
52 week high
$2.42
$6.95

Market cap
$80.56M
Average volume
62,440
P/E ratio
N/A
Rev. per Employee
$76,274
EPS
-5.54
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on SYRS
-
Syros Pharmaceuticals stock price target cut to $10 from $14 at Alliance Global
- Tomi Kilgore
-
Syros Pharmaceuticals stock price target cut to $8 from $10 at Wedbush
- Tomi Kilgore
-
Syros Pharmaceuticals downgraded to neutral from outperform at Wedbush
- Tomi Kilgore
-
Syros Pharmaceuticals started at outperform with $18 stock price target at Wedbush Securities
- Tomi Kilgore
-
Syros Pharmaceuticals sets IPO price expectations
- Tomi Kilgore
-
Syros Pharmaceuticalsto offer 4 mln shares in its IPO
- Tomi Kilgore
-
Syros Pharmaceuticals expects IPO price of between $14 and $16 a share
- Tomi Kilgore
Analyst Ratings
-
5 Keys To Understanding Syros Pharma's ASH Presentation
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For August 10, 2017
- Benzinga.com
Other News on SYRS
-
10-Q: SYROS PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
10-K: SYROS PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Top 5 4th Quarter Trades of ADAGE CAPITAL PARTNERS GP, L.L.C.
- GuruFocus.com
-
10-Q: SYROS PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
Press Releases on SYRS
-
Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update
- BusinessWire - BZX
-
Syros to Present at JMP Securities 2023 Life Sciences Conference
- BusinessWire - BZX
-
Syros to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Syros to Participate in Upcoming Investor Conferences in March
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Syros Announces Clinical Updates and 2023 Strategic Priorities
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Syros to Participate at Piper Sandler 34th Annual Healthcare Conference
- BusinessWire - BZX
-
Syros to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com